Aflac Inc. (AFL) Financial Statements
Historical financial data — 40 statements covering FY2016–FY2025
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include acci...
Aflac Inc.'s revenue decreased 9.3% year over year, from $18.93B to $17.16B.
Net income decreased 33.0% over the same period, from $5.44B to $3.65B.
Over the 9-year period from FY2016 to FY2025, revenue declined by 24% in total.
Operating cash flow declined 5.6% to $2.56B.
Aflac Inc. maintains a strong net profit margin of 21.2%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2023 | $9.97B+107.7% | $2.82B | N/A | $3.17B | $1.09B | $130.63B | N/A | $20.44B |
| Q3 FY2023 | $14.92B+49.6% | $4.39B | N/A | $4.97B | $2.36B | $125.11B | N/A | $22.67B |
| Q1 FY2024 | $5.44B-63.6% | $1.88B | N/A | $2.17B | $849.0M | $124.74B | N/A | $23.54B |
| Q2 FY2024 | $10.57B+94.5% | $3.63B | N/A | $4.19B | $1.10B | $120.17B | N/A | $26.05B |
| Q1 FY2025 | $3.40B-67.9% | $29.0M | N/A | $145.0M | $589.0M | $120.26B | N/A | $26.34B |
| Q2 FY2025 | $7.56B+122.4% | $628.0M | N/A | $967.0M | $988.0M | $124.74B | N/A | $27.20B |
| Q3 FY2025 | $12.30B+62.7% | $2.27B | N/A | $2.96B | $2.24B | $122.31B | N/A | $28.69B |
| Q1 FY2026 | $4.35B-64.7% | $1.02B | N/A | $1.23B | $968.0M | $116.28B | N/A | $29.96B |
Balance Sheet Summary (Latest Period)
Total Assets
$116.47B
Total Liabilities
$86.98B
Total Equity
$29.49B
Cash & Equivalents
$6.25B
Total Debt
N/A
Current Assets
N/A
Current Liabilities
N/A
Retained Earnings
$54.68B